Classic Blog - Cutting Edge Spine

Posted June 25, 2021

Cutting Edge Spine Announces Notice of Issuance from the U.S. Patent and Trademark Office regarding Patent No. US 10,993,754 B2: IMPLANTS FOR TISSUE FIXATION AND FUSION

This patent issuance solidifies Cutting Edge Spine as an industry leader in 3D printed trabecular fixation for orthopedic applications. Mineral Springs, NC June 17, 2020 Cutting Edge Spine [...]

0 Read More

By bradr

In Articles

Posted January 13, 2020

Cutting Edge Spine Announces FDA 510(K) Clearance of its New HA Enhanced PEEK Interbody System for a Direct Lateral Approach to the Spine, the EVOL®ha-DLIF

Cutting Edge Spine, a leader in the development and commercialization of bioactive spinal solutions, today announced the 510(K) clearance and commercial launch of the latest addition to its [...]

0 Read More

By bradr

In EVOL-SI

Posted August 20, 2019

FDA 510(K) Clearance of its EVOL-SI Joint Fusion System

The commercialization of the EVOL-SI system addresses the needs of orthopedic surgeons and neurosurgeons seeking superior clinical outcomes following sacral-iliac surgery. Waxhaw, NC August 20, [...]

0 Read More

By bradr

In EVOL®HA-C

Posted July 11, 2018

FDA 510(K) Clearance of its New HA Enhanced PEEK Interbody for the Cervical Spine, the EVOL ha-C

Cutting Edge Spine, a US leader in the development and commercialization of bio-active technologies for the spine, today announced the 510(k) clearance and commercial launch of it’s latest [...]

0 Read More

By bradr

In EVOS

Posted June 15, 2015

the EVOS System and FDA 510(k) Clearance

Cutting Edge Spine, a technology driven developer and marketer of highly differentiated implant systems, announced that the US Food and Drug Administration has cleared the EVOS-ha, a [...]

0 Read More